Table 3.
Coefficients for the relationship between prostate-specific antigen (PSA) and age for the Krimpen study, the Scandinavian Prostatic Cancer Group 4 (SPCG-4) cohort, and the UK cohort
| Krimpen study | SPCG-4 cohort | UK cohort | |
|---|---|---|---|
| PSA level at age 50, ng/ml (95% CI) | 0.8 (0.7–0.8) |
0.8 (0.6–1.2) | 3.1 (2.7–3.6) |
| Relative increase in PSA per year in age, % (95% CI) |
4.0 (3.7–4.5) |
16.4 (14.0–18.8) |
4.1 (3.1–5.2) |
CI = confidence interval.